Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell Transplantation

Published:2020-11 Issue:11 Volume:26 Page:2147-2154
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chen George L.,Wallace Paul K.,Zhang Yali,Tario Joseph D.,Przespolewski Amanda C.,Becker Joanne,Almyroudis Nikolaos G.,Ross Maureen,Riches Marcie,Segal Brahm H.,Brix Liselotte,McCarthy Philip L.,Hahn Theresa

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference25 articles.

1. Cytomegalovirus in hematopoietic stem cell transplant recipients;Ljungman;Hematol Oncol Clin North Am,2011

2. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection;Nichols;J Infect Dis,2002

3. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis;Teira;Blood,2016

4. Control of cytomegalovirus viremia after allogeneic stem cell transplantation: a review on CMV-specific T cell reconstitution;van der Heiden;Biol Blood Marrow Transplant,2018

5. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity;Boeckh;Blood,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of spontaneous cytomegalovirus clearance after low level reactivation using a pre-emptive treatment threshold of 4,000 IU/mL in allogeneic hematopoietic cell transplant recipients;Journal of Infection and Chemotherapy;2024-05

2. CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia;Blood Advances;2023-06-14

3. Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant;Haematologica;2022-10-20

4. Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study;Vaccines;2021-04-12

5. Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses;Blood Advances;2021-01-22